Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 37, 2002 - Issue 4
Submit an article Journal homepage
56
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Effects of Platelet Activating Factor, Butyrate and Interleukin-6 on Cyclooxygenase-2 Expression in Human Esophageal Cancer Cells

L.-S. Wang
,
K.-C. Chow
&
Y.-C. Wu
Pages 467-475 | Published online: 08 Jul 2009

  • Wu YK, Chen PT, Fahn JP, Lin SS. Surgical treatment of esophageal carcinoma. Am J Surg 1980;139:805-9.
  • Wang LS, Chow KC, Chi KH, Liu CC, Li WY, Chiu JH, Huang MH. Prognosis of esophageal squamous cell carcinomaanalysis of clinicopathological and biological factors. Am J Gastroenterol 1999:94:1933 -40.
  • Munoz N, Crespi M, Grassi A, Qing WG, Quiong S, Cai LZ.Precursor lesions of esophageal cancer in high-risk populations in Iran and China. Lancet 1982;i:876-9.
  • Crespi M, Munoz N, Grassi A, Qiong S, Jing WK, Jien LJ.Precursor lesions of esophageal cancer in low-risk population in China: comparison with high-risk populations. Int J Cancer 1984:34:599-602.
  • Punkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995;76:1116-9.
  • Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993;53: 1322-7.
  • Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994:5:138-46.
  • Subbaramaiah K, Zakim D, Weksler BB, Dannenberg AJ. Inhibition of cyclooxygenase : a novel approach to cancer prevention. Proc Soc Exp Biol Med 1997:216:201 -10.
  • Smith WL, Mamett LJ. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta 1991:1083:1-17.
  • HIa T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Nail Acad Sei USA 1992:89:7384-8.
  • Hempel SL, Monick MM, Hunninghake GW. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 1994:93:391 -6.
  • Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-1 B, phorbol ester, and corticosteroids. J Clin Invest 1994:93:1095-101.
  • Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1996:1299:125-40.
  • Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999; 59:991-4.
  • Parrett ML, Harris RE, Joarder FS, Ross MS, Clause KP, Robert so n FM. Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol 1997:10:503-7.
  • Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998:58:4997-5001.
  • Ristimaki A, Honkanen H, Jänkälä H, Sipponen P, Härkönen M. Expression of cyclooxygenase-2 in human gastric carcinoma.Cancer Res 1997:57:1276-80.
  • Eberhart CE, Coffey RJ, Radhika A, Giaidiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.Gastroenterology 1994;107:1183-8.
  • Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schrör K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999;59:198-204.
  • Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, DaIy JM, et al. Cyclooxygenase- 2 expressio n is up-regulated in human pancreatic cancer. Cancer Res 1999:59:987-90.
  • Bennett A, Tacca MD, Stamford IF, Zebro T. Prostaglandins from tumours of human large bowel. Br J Cancer 1977;35:881 -4.
  • Qiao L, Kozoni V, Tsioulias GJ, Koutsos MI, Hanif R, Shiff SJ, et al. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim Biophys Acta 1995; 1258:215 -23
  • HIaT,Ristimaki A, Appleby S, Barriocanal JG. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann NY AcadSci 1993:696:197-204.
  • Kikkawa UY, Takai Y, Tanaka R, Miyake, Nishizuka Y. Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J Biol Chem 1983;258:11442-5.
  • Wang LS, Chow KC. Wu CW. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodhim butyrate. Br J Cancer 1999;80:1617-22.
  • Derewenda ZS, Derewenda U. The structure and function of platelet-activating factor acetylhydrolases. Cell MoI Life Sci 1998:54:446-55.
  • Foa R, Bussolino F, Fernando ML, Guarini A, Tetta C, Mazzone R, et al. Release of platelet-activatin g factor in human leukemia. Cancer Res 1985;45:4483-5.
  • HIa T, Neilson K. Human cyclooxygenase- 2 cDNA. Proc Nail Acad Sci USA 1992;89:7384-8.
  • Kunz D, Gerard NP, Gerard C. The human leukocyte plateletactivating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearin g analog. J Biol Chem 1992:267:9101 -6.
  • Chow KC, Pearson GD. Adenovirus infection elevates levels of cellular topoisomerase I. Proc Nail Acad Sci USA 1985;82: 2247-51.
  • Kosaka T, Miyata A, Ihara H, Hara S, Sugimoto T, Takeda O, et al. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxid e synthase 2. Ear J Biochem 1994; 221:889-97.
  • Petkova DK, Pang L, Range SP, Holland E, Knox AJ. Immunocytochemical localization of cyclo-oxygenas e isoform s in cultured human airway structural cells. Clin Exp Allergy 1999:29:965-72.
  • Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Kobold! C, et al. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 1999;59:2347-52.
  • Meade EA, Mclntyre TM, Zimmerman GA, Prescott SM.Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem 1999;274:8328-34.
  • Lukiw WJ, Pelaez RP, Martinez J, Bazan NG. Budesonide epimer R or dexamethason e selective! y inhibit platelet-activatin g factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase2 gene expression in human epidermal keratinocytes. Proc Natl Acad Sci USA 1998;95:3914-9.
  • Maloney CG, Kutchera WA, Albertine KH, Mclntyre TM, Prescott SM, Zimmerman GA. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J Immunol 1998;160:1402-10.
  • Belvisi MG, Saunders MA, Haddad el-B, Hirst SJ, Yacoub MH, Barnes PJ, et al. Induction of cyclo-oxygenase- 2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol 1997;120:910-6.
  • Barry OP, Kazanietz MG, Pratico D, FitzGerald GA. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandi n formation via a protein kinase Clmitogen-activaled protein kinase-dependen t pathway. J Biol Chem 1999:274:7545-56.
  • Pang L, Holland E, Knox AJ. Role of cyclo-oxygenase- 2 induction in interleukin-lbeta induced attenuation of cultured human airway smooth muscle cell cyclic AMP generation in response to isoprenaline. Br J Pharmacol 1998;125:1320-8.
  • Subbaramaiah K, Chung WJ, Dannenberg AJ. Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase/c-Jun Nterminal kinase and p38 mitogen-activated protein kinase pathways. J Biol Chem 1998;273:32943-9.
  • Klein T, Ullrich V, Pfeilschifter J, Nusing R. On the induction of cyclooxygenase-2, inducible nitric oxide synthase and soluble phospholipase A2 in rat mesangial cells by a nonsteroidal antiinflammatory drug: the role of cyclic AMP. MoI Pharmacol 1998:53:385-91.
  • Johnson CD. Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis. Dig Surg 1999; 16:93101.
  • Kutchera W, Jones DA, Matsunami N, Groden J, Mclntyre TM, Zimmerman GA, et al. Prostaglandin H synthase 2 is expressed abnormall y in human colon cancer: evidence for a transcriptiona 1 effect. Proc Natl Acad Sci USA 1996;93:4816-20.
  • Chow KC, Chen KY. The role of Epstein-Barr virus infection and the immunocompetence of patients with nasopharyngeal cancers.Therapeutic Radiol Oncol 19952:243-60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.